Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiri Mayer

Showing results (31-40 of 223) with videos related to

Pageof 23
Sort By:
American Journal of Hematology|October 29, 2010
Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutationsDana Dvorakova, Zdenek Racil, Ivana Jeziskova, et al.
Tumori|December 24, 2013
Salvage lenalidomide in four rare oncological diseasesPetr Szturz, Zdenek Adam, Zdenek Rehak, et al.
Journal of Clinical Microbiology|January 19, 2007
Real-time PCR diagnostics failure caused by nucleotide variability within exon 4 of the human cytomegalovirus major immediate-early geneMartina Lengerova, Zdenek Racil, Pavlina Volfova, et al.
Leukemia & Lymphoma|October 2, 2012
Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutationsDana Dvorakova, Zdenek Racil, Marek Borsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2007
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemiaPeter Hillmen, Aleksander B Skotnicki, Tadeusz Robak, et al.
Experimental Hematology|March 3, 2012
A real-time (PCR) for a real life…? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practiceAndrea Janikova, Andrea Mareckova, Dana Dvorakova, et al.
Experimental Hematology|August 6, 2009
Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patientsAndrea Janikova, Zdenek Koristek, Jaroslava Vinklarkova, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 19, 2014
Detecting human cytomegalovirus drug resistant mutations and monitoring the emergence of resistant strains using real-time PCRPavlina Volfova, Martina Lengerova, Jana Lochmanova, et al.
Plos One|August 14, 2019
Application of mini-MLST and whole genome sequencing in low diversity hospital extended-spectrum beta-lactamase producing Klebsiella pneumoniae populationMatej Bezdicek, Marketa Nykrynova, Kristina Plevova, et al.
American Journal of Hematology|June 16, 2011
Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilizationGrzegorz W Basak, Ozren Jaksic, Zdenek Koristek, et al.
Pageof 23

Showing results (31-40 of 223) with videos related to

Sort By:
Pageof 23
American Journal of Hematology|October 29, 2010
Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutationsDana Dvorakova, Zdenek Racil, Ivana Jeziskova, et al.
Tumori|December 24, 2013
Salvage lenalidomide in four rare oncological diseasesPetr Szturz, Zdenek Adam, Zdenek Rehak, et al.
Journal of Clinical Microbiology|January 19, 2007
Real-time PCR diagnostics failure caused by nucleotide variability within exon 4 of the human cytomegalovirus major immediate-early geneMartina Lengerova, Zdenek Racil, Pavlina Volfova, et al.
Leukemia & Lymphoma|October 2, 2012
Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutationsDana Dvorakova, Zdenek Racil, Marek Borsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2007
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemiaPeter Hillmen, Aleksander B Skotnicki, Tadeusz Robak, et al.
Experimental Hematology|March 3, 2012
A real-time (PCR) for a real life…? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practiceAndrea Janikova, Andrea Mareckova, Dana Dvorakova, et al.
Experimental Hematology|August 6, 2009
Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patientsAndrea Janikova, Zdenek Koristek, Jaroslava Vinklarkova, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 19, 2014
Detecting human cytomegalovirus drug resistant mutations and monitoring the emergence of resistant strains using real-time PCRPavlina Volfova, Martina Lengerova, Jana Lochmanova, et al.
Plos One|August 14, 2019
Application of mini-MLST and whole genome sequencing in low diversity hospital extended-spectrum beta-lactamase producing Klebsiella pneumoniae populationMatej Bezdicek, Marketa Nykrynova, Kristina Plevova, et al.
American Journal of Hematology|June 16, 2011
Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilizationGrzegorz W Basak, Ozren Jaksic, Zdenek Koristek, et al.
Pageof 23